UK markets closed
  • NIKKEI 225

    28,249.24
    +73.37 (+0.26%)
     
  • HANG SENG

    20,045.77
    -156.17 (-0.77%)
     
  • CRUDE OIL

    90.49
    +1.48 (+1.66%)
     
  • GOLD FUTURES

    1,786.40
    +13.50 (+0.76%)
     
  • DOW

    32,832.54
    +29.07 (+0.09%)
     
  • BTC-GBP

    19,799.70
    +399.40 (+2.06%)
     
  • CMC Crypto 200

    559.83
    +16.96 (+3.12%)
     
  • ^IXIC

    12,644.46
    -13.10 (-0.10%)
     
  • ^FTAS

    4,132.82
    +21.31 (+0.52%)
     

Barcelona's Impress heads toward a $125M Series B round in its bid to digitize orthodontics

·1-min read

Last year we covered how Barcelona-based startup Impress had digitalized the area of orthodontics, raising a $50 million Series A in the process, somewhat aping U.S.-based startups such as SmileDirect.

Usually, consumers can only access cosmetic teeth alignment or orthodontic medical treatments in conventional clinics. This new wave of technology involves 3D scans and panoramic X-rays to check nerve and bone health, as well as telehealth apps that allow patients to monitor their progress and check-in with the clinics.

Impress has its own chain of orthodontic clinics in southern Europe and plans to expand internationally.

It now says it has raised $100 million of a proposed $125 million Series B round, with the second closing of $25 million on its way, the company says.

Founded in 2019 in Barcelona by orthodontist Dr. Khaled Kasem and entrepreneurs Diliara and Vladimir Lupenko, it now has a presence in 130+ European cities, spread across 8 countries.

In a statement, Vladimir Lupenko said: “We created an absolutely new orthodontic experience powered by tech. All of the processes are fully digitalized thanks to Impress' own product and software. This accomplishment would not have been possible without close contact between our patients and medical team, because this is the only way we can understand their needs and expectations.”

Valéry Huot, partner/head of Venture at LBO France, said: “Impress is disrupting the orthodontics market while maintaining medical excellence and patient care at highest level."

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting